What are FOXM1 antibodies?
Anti-FOXM1 antibodies are immunoglobulins that specifically recognize and bind FOXM1, the gene encoding forkhead box protein M1 in humans. These antibodies are used for immunodetection across general sample types such as tissue samples, cell lysates, and cultured cells. FOXM1 is a forkhead-family transcription factor that drives expression of cell-cycle genes required for DNA replication and mitotic entry. FOXM1 is broadly overexpressed across solid tumors and supports proliferation and chemoresistance, making it one of the most studied proliferation-associated transcription factors in cancer.
Catalog highlights and purchasing considerations
About the Biocompare FOXM1 catalog
The Biocompare antibody search tool lists anti-FOXM1 antibodies from a range of suppliers, spanning polyclonal and monoclonal formats validated across multiple applications. Western blot, ELISA, and immunocytochemistry are the most common validated applications among these products. In addition, the FOXM1 antibodies mentioned here have been cited in research including studies on FOXM1-targeted TCR-engineered T cells and FOXM1 in platelet-induced anoikis resistance.
Considerations when choosing a FOXM1 antibody for research
Confirm that the antibody's intended target is accurate, as many genes carry synonym symbols that can create ambiguity across suppliers. Specificity should be verified against the immunogen sequence or region listed on the product datasheet, since antibodies raised against different epitopes of the same protein can behave differently across applications. Beyond specificity, several target-related attributes can affect antibody binding, including subcellular location, extracellular and cytoplasmic domain boundaries for membrane-associated targets, tissue specificity, post-translational modifications, and the presence of additional isoforms or disease-associated variants. In parallel, antibody-specific selection criteria include clonality (monoclonal versus polyclonal), host species, species reactivity, and the choice of conjugate or label suited to the intended detection method. Supplier-provided validation data, such as western blot bands at the expected molecular weight, immunohistochemistry staining patterns consistent with known tissue distribution, or knockout and knockdown controls, is widely regarded as the most reliable final check before purchase.